IB
Universal Ibogaine Inc.
IBOGF · OTC
$0.00 N/A (+$0.00)
1M -96.09%
Market Cap $11.5M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
34 /100
Fair P/S 10.75x
P/B 2.92x
P/E N/A
Growth
100 /100
Growing Book val. growth 171.46%
EPS growth N/A
FCF growth N/A
Profitability
50 /100
Moderate Gross margin 100.00%
FCF margin 413.60%
Net margin 980.22%
Quality
30 /100
Poor ROIC 8.70%
Asset turnover 0.17x
ROA 166.14%
Debt
73 /100
Low Debt/Equity 0.44x
Net debt/EBITDA -0.22x
Current ratio 1.60x
Stability
1 /100
Unstable Beta 4.38x
Profitable years 0
EPS volatility 105.25%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na IBOGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Nicholas Peter Karos
Employees
7
Headquarters
Calgary